Actively Recruiting
Using Optical Coherence Tomography to Objectively Measure Eye Inflammation in Uveitis and Related Conditions
Led by Oregon Health and Science University · Updated on 2025-07-17
125
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a new method using a high resolution imaging device called optical coherence tomography OCT to count and classify different types of cells and proteins involved in anterior uveitis, which is inflammation in the front part of the eye caused by various systemic diseases. The study aims to create an unbiased, standard way to measure and understand this eye condition. This observational study includes participants with different eye conditions and healthy controls to compare findings. Participants are divided into three groups those with active inflammation from diseases like spondyloarthritis, juvenile idiopathic arthritis, herpes simplex virus uveitis, birdshot chorioretinitis, Behcet disease, sarcoidosis, or other types of uveitis those with vitreous floaters and posterior vitreous detachment and healthy individuals with no history of eye inflammation, vitreous detachment, or eye surgery. The study uses OCT imaging to assess these groups and gather detailed eye cell and protein data. During the study, participants undergo OCT imaging and related eye assessments on Day 1 to identify and measure anterior chamber cells, flare, keratic precipitates, vitreous cells, and vitreous haze. The study tracks these eye inflammation markers without any treatment intervention. Participants must be between 5 and 85 years old and able to maintain steady eye fixation during imaging. The study continues until December 2026, with all visits and evaluations documented for research purposes.
CONDITIONS
Brief Title
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Research Team
H
Humberto Martinez, COT, MBA
D
Denzil Romfh, OD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here